FDA Inspection 1308772 — Institute For Reproductive Medicine And Science At Saint Barnabas, P.A.
The FDA completed an inspection of Institute For Reproductive Medicine And Science At Saint Barnabas, P.A. on Mar 13, 2026 in Livingston, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 13, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Livingston, NJ (United States)